| Similar Articles |
|---|
 |
Bio-IT World
Jul/Aug 2006 |
News Blast Health Solutions... Rna Interference... HIV Triple Combo...   |
Bio-IT World
November 2006
Kevin Davies |
Merck's $1.1 Billion Bet on RNAi As if the 2006 Nobel Prize in Medicine or Physiology wasn't validation enough, Merck's acquisition of biotech firm Sirna for $1.1 billion last month offered evidence of the commercial implications of RNA interference gene-silencing technology. |
InternetNews
August 5, 2004
Clint Boulton |
Mayo Clinic to Use IBM's Blue Gene The clinic will use IBM's supercomputer to map current and historical patient records and link them to new types of medical information. |
The Motley Fool
August 15, 2006
Ralph Casale |
Sirna Battles Genes Gone Bad Pharmaceutical start-up Sirna Therapeutics tests drugs to silence rogue genes. Investors, while drugs based on RNA interference may have the potential to become the next big thing in biotechnology, they're still a long, long way from becoming FDA-approved, marketable entities. |
Bio-IT World
December 15, 2004
Nancy Weil |
Running Interference The revolution in RNA interference has galvanized basic research. Now, some biopharmas are pushing the technology from the laboratory to the clinic. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Southwest Region Texas: Bioscience with a Space Spin... New Mexico: Building a Bioinformatics Niche... Arizona: Focus on Cancer and Neurological Therapy... Southern California: Deep Biotech Roots Grow Many Branches... Northern California: 'Can You Afford To Be Elsewhere?'... |
Bio-IT World
June 2005
Nancy Weil |
Dharmacon Signs Library Deal The biopharma is providing its genome-wide short-interfering RNA (siRNA) library to Millennium Pharmaceuticals. This is the first commercial siRNA collection that targets genes across the entire human genome, encompassing some 22,000 genes. |
Bio-IT World
September 2005 |
News Blast Cancer Signs... Arizona Award... Nhgri Grant... Product Pact... |
The Motley Fool
February 9, 2006
Jason Mac Gurn |
RNA: Rule Breaker Nucleic Acid Investors, new RNA-based technologies may be the next revolution in biopharmaceuticals. ISIS Pharmaceuticals... Sirna Therapeutics... Alnylam Pharmaceuticals... |
Bio-IT World
December 15, 2003
Mark D. Uehling |
A Diamond in the Desert Drawn by impressive research budgets, talent, and 'serendipity,' a prodigal son returns to build a biotech oasis in Phoenix. |
Bio-IT World
November 2005
G. Steven Burrill |
Biotech Posts Strong Third Quarter Despite overall subpar numbers in September, as compared with the previous four months, this was another excellent quarter for biotech... A good quarter for collaborations... IPO windows open slowly... Biotech still attractive for big pharmaceuticals... |
BusinessWeek
February 21, 2005
Gene G. Marcial |
Iridex May Open More Investors' Eyes Iridex's stock price has fluctuated since initial results of clinical trials on its transpupillary thermotherapy product for age-related [wet] macular degeneration, a leading cause of blindness. |
CIO
October 27, 2010
Cindy Waxer |
How Mayo Clinic Doctors Use Smartphones to Diagnose Patients Neurologists diagnose patients remotely using images delivered to smartphones. |
Bio-IT World
August 2005 |
Project Summaries Summaries of candidates for Bio-IT World's "Best Practices 2005" projects. |
Managed Care
May 2001 |
Minnesota Plans, Providers Using Same Guidelines Minnesota's five largest health plans and three major provider systems, including the Mayo Clinic, have agreed to use a standard set of evidence-based treatment guidelines developed by the Institute for Clinical Systems Improvement... |
Bio-IT World
July 15, 2003
Malorye Branca |
Silence Is Golden RNA interference's scientific, therapeutic, and economic potential is unquestionable, but some sticky questions still remain. |
Fast Company
July 2009
Kate Rockwood |
How Mayo Clinic and Microsoft Are Empowering Patients The Mayo Clinic Health Manager free Web application, launched in April, supports data from health-monitoring devices, stores family medical records using Microsoft's HealthVault, and offers guidance and reminders from the Mayo Clinic. |
Chemistry World
November 26, 2014
Rebecca Trager |
Gates Foundation champions open access The Bill & Melinda Gates Foundation, based in Washington, US, has adopted a new policy that requires free, unrestricted access and reuse of all peer-reviewed published research that the foundation funds |
InternetNews
January 9, 2008
Larry Barrett |
IBM, Mayo Clinic Open Imaging Research Center IBM's high-end imaging platforms and hardware will be used to improve the speed and clarity of medical images used by physicians and radiologists. |
Bio-IT World
May 9, 2003
Julia Boguslavsky |
MS Goes Through the Roof Mass spectrometry goes through the roof when the Mayo Clinic installs its new machine. |
